» Articles » PMID: 27901086

Glycycoumarin Inhibits Hepatocyte Lipoapoptosis Through Activation of Autophagy and Inhibition of ER Stress/GSK-3-mediated Mitochondrial Pathway

Overview
Journal Sci Rep
Specialty Science
Date 2016 Dec 1
PMID 27901086
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Herbal medicine as an alternative approach in the treatment of disease has drawn growing attention. Identification of the active ingredient is needed for effective utilization of the herbal medicine. Licorice is a popular herbal plant that is widely used to treat various diseases including liver diseases. Glycycoumarin (GCM) is a representative of courmarin compounds isolated from licorice. In the present study, the protective effect of GCM on hepatocyte lipoapoptosis has been evaluated using both cell culture model of palmitate-induced lipoapoptosis and animal model of non-alcoholic steatohepatitis (NASH). The results demonstrated for the first time that GCM was highly effective in suppressing hepatocyte lipoapoptosis in both in vitro and in vivo. Mechanistically, GCM was able to re-activate the impaired autophagy by lipid metabolic disorders. In line with the activation of autophagy, ER stress-mediated JNK and mitochondrial apoptotic pathway activation was inhibited by GCM both in vitro and in vivo. In addition, inactivation of GSK-3 might also contribute to the protective effect of GCM on hepatocyte lipoapoptosis. Our findings supported GCM as a novel active component of licorice against non-alcoholic fatty liver disease (NAFLD).

Citing Articles

Strategy for treating MAFLD: Electroacupuncture alleviates hepatic steatosis and fibrosis by enhancing AMPK mediated glycolipid metabolism and autophagy in T2DM rats.

Duan H, Song S, Li R, Hu S, Zhuang S, Liu S Diabetol Metab Syndr. 2024; 16(1):218.

PMID: 39261952 PMC: 11389443. DOI: 10.1186/s13098-024-01432-7.


An Ethnopharmaceutical Study on the Hypolipidemic Formulae in Taiwan Issued by Traditional Chinese Medicine Pharmacies.

Chi M, Chao J, Ko C, Huang S Front Pharmacol. 2022; 13:900693.

PMID: 36188612 PMC: 9520573. DOI: 10.3389/fphar.2022.900693.


mTOR: A Potential New Target in Nonalcoholic Fatty Liver Disease.

Feng J, Qiu S, Zhou S, Tan Y, Bai Y, Cao H Int J Mol Sci. 2022; 23(16).

PMID: 36012464 PMC: 9409235. DOI: 10.3390/ijms23169196.


Enhancement of TEX264-Mediated ER-Phagy Contributes to the Therapeutic Effect of Glycycoumarin against APA Hepatotoxicity in Mice.

Yan M, Wang Z, Xia T, Jin S, Liu Y, Hu H Biomedicines. 2021; 9(8).

PMID: 34440143 PMC: 8394328. DOI: 10.3390/biomedicines9080939.


Protein Phosphatase 4 Promotes Hepatocyte Lipoapoptosis by Regulating RAC1/MLK3/JNK Pathway.

Huang X, Yang G, Zhao L, Yuan H, Chen H, Shen T Oxid Med Cell Longev. 2021; 2021:5550498.

PMID: 34221233 PMC: 8221892. DOI: 10.1155/2021/5550498.


References
1.
Mota M, Banini B, Cazanave S, Sanyal A . Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism. 2016; 65(8):1049-61. PMC: 4931958. DOI: 10.1016/j.metabol.2016.02.014. View

2.
Cazanave S, Elmi N, Akazawa Y, Bronk S, Mott J, Gores G . CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis. Am J Physiol Gastrointest Liver Physiol. 2010; 299(1):G236-43. PMC: 2904106. DOI: 10.1152/ajpgi.00091.2010. View

3.
Takahashi Y, Soejima Y, Fukusato T . Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol. 2012; 18(19):2300-8. PMC: 3353364. DOI: 10.3748/wjg.v18.i19.2300. View

4.
Kim K, Jeong Y, Oh H, Kim S, Cho J, Kim Y . Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat Med. 2012; 19(1):83-92. DOI: 10.1038/nm.3014. View

5.
Song X, Yin S, Huo Y, Liang M, Fan L, Ye M . Glycycoumarin ameliorates alcohol-induced hepatotoxicity via activation of Nrf2 and autophagy. Free Radic Biol Med. 2015; 89:135-46. DOI: 10.1016/j.freeradbiomed.2015.07.006. View